Huh Hoyoung
SEC CIK 1401267 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AKTX | Akari Therapeutics Plc | Dir, 10% | 4.70M | — | — | 1 | 2025-03-06 | 2025-03-06 |
Most active insiders at AKTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Farag Kameel D. | Interim CFO | — | — |
| 2 | Patel Samir Rashmikant | Dir, 10% | — | — |
Huh Hoyoung made no open-market trades at AKTX in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-10 | 2025-03-06 | AKTX | Akari Therapeutics Plc | Huh Hoyoung | Dir, 10% | A - Grant | $1.12 | +892.9K | 4.70M | +23% | +$1000.0K |
Purchase Sale Sale after option exercise All abbreviations